These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20920198)

  • 1. The construct validity of the health utilities index mark 3 in assessing health status in lung transplantation.
    Santana MJ; Feeny D; Ghosh S; Nador RG; Weinkauf J; Jackson K; Schafenacker M; Zuk D; Hubert G; Lien D
    Health Qual Life Outcomes; 2010 Sep; 8():110. PubMed ID: 20920198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The construct validity of the Health Utilities Index Mark 3 in assessing mental health in population health surveys.
    Feeny D; Huguet N; McFarland BH; Kaplan MS
    Qual Life Res; 2009 May; 18(4):519-26. PubMed ID: 19277898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.
    Jones CA; Pohar SL; Feeny DH; Eng K
    Qual Life Res; 2014 Apr; 23(3):805-13. PubMed ID: 24081869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Qual Life Res; 2008 Aug; 17(6):933-42. PubMed ID: 18543076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and psychometric properties of the Pulmonary-specific Quality-of-Life Scale in lung transplant patients.
    Hoffman BM; Stonerock GL; Smith PJ; O'Hayer CV; Palmer S; Davis RD; Kurita K; Carney RM; Freeland K; Blumenthal JA
    J Heart Lung Transplant; 2015 Aug; 34(8):1058-65. PubMed ID: 25980570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.
    Luo N; Seng BK; Thumboo J; Feeny D; Li SC
    Qual Life Res; 2006 Jun; 15(5):889-98. PubMed ID: 16721648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Utilities Index Mark 3 (HUI3) demonstrated construct validity in a Nigerian population with hypertension.
    Ekwunife OI; Aguwa CN; Igboeli NU
    Qual Life Res; 2013 Mar; 22(2):455-8. PubMed ID: 22407384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life and stress-related post-transplant trajectories of lung transplant recipients: a three-year follow-up of the Swiss Transplant Cohort Study.
    Bleisch B; Schuurmans MM; Klaghofer R; Benden C; Seiler A; Jenewein J
    Swiss Med Wkly; 2019 Feb; 149():w20019. PubMed ID: 30961347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.
    Luo N; Johnson JA; Shaw JW; Feeny D; Coons SJ
    Med Care; 2005 Nov; 43(11):1078-86. PubMed ID: 16224300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.
    Bosch JL; Hunink MG
    Qual Life Res; 2000; 9(6):591-601. PubMed ID: 11236850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Value Health; 2009; 12(2):340-5. PubMed ID: 18657096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore.
    Abdin E; Chong SA; Seow E; Peh CX; Tan JH; Liu J; Hui SFS; Chua BY; Sim K; Verma S; Vaingankar JA; Subramaniam M
    Psychiatry Res; 2019 Apr; 274():400-408. PubMed ID: 30852434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
    Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
    Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fractures.
    Slobogean GP; Noonan VK; O'Brien PJ
    J Shoulder Elbow Surg; 2010 Apr; 19(3):342-8. PubMed ID: 20189839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting.
    Lung T; Howard K; Etherton-Beer C; Sim M; Lewin G; Arendts G
    PLoS One; 2017; 12(2):e0172796. PubMed ID: 28234983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.